990x120 QC

Event Overview

Quality control throughout cell therapy research and design is critical to ensuring safety and efficacy. Cell therapy products are at risk of becoming contaminated with bacteria, viruses, or allergenic agents. Defining the parameters of cell quality and routinely assessing cell therapy products is key to therapeutic success.

In this webinar, brought to you by The Scientist and sponsored by Sartorius, Steven Keizer, an expert in designing quality systems to fit the pharmaceutical industry, and Stephen Sullivan, an expert in establishing clinical-grade induced pluripotent stem cells, will discuss how best to define and assess cell quality for therapeutic purposes.

Topics to be covered
  • Cell quality in research and therapeutic applications
  • Quality guidelines for induced pluripotent stem cells to be used for therapeutic development
Friday, June 26, 2020
2:30 - 4:00 PM, Eastern Standard Time


Steven Keizer, PhD, MBA
Director of Quality
CCRM (Centre for Commercialization of Regenerative Medicine)

Stephen Sullivan, PhD, MBA, FRSM
International Liaison Officer
GAiT (Global Alliance for iPSC Therapies)


Register Now

Microbiology Quality Control for Cell Therapies

You must have Javascript and Cookies enabled to access this webcast.

Information you provide will be held in confidence and will be shared with the sponsoring vendor(s) of this webinar. We may use the information to contact you about your account and to let you know about related programs and products; you may opt-out at any time. This allows The Scientist to keep these webinars free of charge for our readers.